Carson Wealth (CWM LLC)’s Co-Diagnostics CODX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$4K Hold
17
﹤0.01% 2413
2021
Q1
$4K Hold
17
﹤0.01% 2413
2020
Q4
$4K Hold
17
﹤0.01% 2413
2020
Q3
$4K Hold
17
﹤0.01% 2413
2020
Q2
$4K Hold
17
﹤0.01% 2413
2020
Q1
$4K Hold
17
﹤0.01% 2413
2019
Q4
$4K Hold
17
﹤0.01% 2412
2019
Q3
$4K Hold
17
﹤0.01% 2412
2019
Q2
$4K Hold
17
﹤0.01% 2412
2019
Q1
$4K Buy
+17
New +$612 ﹤0.01% 2412

Other funds holding CODX

Carson Wealth (CWM LLC)'s CODX Position: Q2 2021 in Review

Carson Wealth (CWM LLC) held its Co-Diagnostics (CODX) position steady in Q2 2021 at 17 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #2413.

Carson Wealth (CWM LLC) first reported a position in CODX in Q1 2019 and has held it in 10 quarters since. 88 funds tracked by Wall St. Rank hold CODX as of Q2 2021.

  • Carson Wealth (CWM LLC) held 17 shares of Co-Diagnostics worth $4K as of Q2 2021.
  • Carson Wealth (CWM LLC) left its Co-Diagnostics share count unchanged in Q2 2021.
  • Co-Diagnostics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q2 2021, its #2413 holding.
  • Carson Wealth (CWM LLC) first reported a position in Co-Diagnostics in Q1 2019 and has held it in 10 quarters since.
  • 88 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2021.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q2 2021, filed 29 Jul 2021.